Amarin Corp Plc (AMRN)

[jessellivermore]

Pharmadude...

Quote: "If GV becomes available every V script will be filled with GV if it is cheaper than V."...

This is going to depend on the indication..,For the MARINE (High trigs label) Gen Lovaza will continue to be the substitute of choice because it will be cheaper than G Vascepa..(and has the same FDA Indication and usage.).

Here is the part everyone should enjoy...Since Generics have not won the right to the REDUCE-IT label..(they only have the MARINE hi trigs indication). Then only Amarin can sell Vascepa for the REDUCE-IT (CVD lowering indication)..The generics can plan on "off label" sale of V for the REDUCE IT indication..but this will not work..The drug plans will apply the law and restrict Gen V for MARINE trig levels because they could be sued for patent infringement..So they will just convert to Gen L regardless of the generics wishes to prescribe off label...

Amarin alone has the right to the R_I label...and there is no cheaper alternative..And Amarin could (will) sue the drug plans if they converts its scripts)...That law suit will be coming down the road...

Don't sell your Amarin shares..Buy more if you can..better time are coming soon regardless of the results of the Appeal.

":>) JL